Showing results (191-200 of 215) with videos related to
Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2023
Intraoperative Integrated Diagnostic System for Malignant Central Nervous System TumorsTakahiro Hayashi, Kensuke Tateishi, Shinichiro Matsuyama, et al.Nature Communications|October 7, 2023
Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomasMark W Youngblood, Zeynep Erson-Omay, Chang Li, et al.Science (New York, N.Y.)|June 20, 2020
Partitioning of cancer therapeutics in nuclear condensatesIsaac A Klein, Ann Boija, Lena K Afeyan, et al.Nature Genetics|December 1, 2015
Integrated genomic characterization of IDH1-mutant glioma malignant progressionHanwen Bai, Akdes Serin Harmancı, E Zeynep Erson-Omay, et al.Nature Medicine|May 4, 2021
Evolution of delayed resistance to immunotherapy in a melanoma responderDavid Liu, Jia-Ren Lin, Emily J Robitschek, et al.Acta Neuropathologica|August 21, 2018
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcomeTareq A Juratli, Devin McCabe, Naema Nayyar, et al.Nature|November 5, 2016
Single-cell RNA-seq supports a developmental hierarchy in human oligodendrogliomaItay Tirosh, Andrew S Venteicher, Christine Hebert, et al.Journal of Neurosurgery|October 27, 2019
Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomasMark W Youngblood, Daniel Duran, Julio D Montejo, et al.Cell|February 16, 2021
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysisNathan D Mathewson, Orr Ashenberg, Itay Tirosh, et al.Biorxiv : the Preprint Server for Biology|September 11, 2023
Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacyAlbert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.Pageof 22